Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26624407 | 1.00 | ALOX15 (0.48) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL8153609 | 0.77 | ALOX15 (0.68) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL27529971 | 0.75 | ALOX15 (0.61) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL942435 | 0.75 | ALOX15 (0.47) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL11779305 | 0.74 | ALOX15 (0.53) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL12025426 | 0.72 | — | — | |
| SCHEMBL11122805 | 0.72 | ALOX15 (0.56) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL14721883 | 0.72 | ALOX15 (0.43) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL722489 | 0.71 | ALOX15 (0.85) | ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL30492702 | 0.71 | ALOX15 (0.85) | ALOX15MEN1CYP3A4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015397-A1 | Selective Aliphatic C-H Oxidation | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-01-20 | — | — | US | disclosed |
| US-7829342-B2 | composition including a complex of a metal, a tetradentate ligand, at least one ancillary ligand, and a counterion is used for selective sp3 C H bond oxidation; includes a N-heterocyclic-N,N'-bis(pyridyl)-ethane-1,2-diamine group or a N,N'-bis(heterocyclic)-N,N'-bis(pyridyl)-ethane-1,2-diamine group | THE BOARD OF TRUSTEES OF THE UNIVERSIY OF ILLINOIS (US) | 2010-11-09 | — | — | US | disclosed |
| US-20090221083-A1 | Selective Aliphatic C-H Oxidation | BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015397-A1 | Selective Aliphatic C-H Oxidation | AOC3, SOD3, AP3S1 | ALOX15 2139/4885MEN1 4490/4885CYP3A4 1846/4885 |
| US-20090221083-A1 | Selective Aliphatic C-H Oxidation | AOC3, SOD3, AP3S1 | ALOX15 2139/4885MEN1 4490/4885CYP3A4 1846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.